Cargando…

Double Recombinant Vaccinia Virus: A Candidate Drug against Human Glioblastoma

Glioblastoma is one of the most aggressive brain tumors. Given the poor prognosis of this disease, novel methods for glioblastoma treatment are needed. Virotherapy is one of the most actively developed approaches for cancer therapy today. VV-GMCSF-Lact is a recombinant vaccinia virus with deletions...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vasileva, Natalia, Ageenko, Alisa, Dmitrieva, Maria, Nushtaeva, Anna, Mishinov, Sergey, Kochneva, Galina, Richter, Vladimir, Kuligina, Elena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8538059/ https://www.ncbi.nlm.nih.gov/pubmed/34685455 http://dx.doi.org/10.3390/life11101084

Ejemplares similares

Engineering of double recombinant vaccinia virus with enhanced oncolytic potential for solid tumor virotherapy
por: Kochneva, Galina, et al.
Publicado: (2016)

Recombinant Vaccinia Viruses Coding Transgenes of Apoptosis-Inducing Proteins Enhance Apoptosis But Not Immunogenicity of Infected Tumor Cells
por: Koval, Olga, et al.
Publicado: (2017)

MicroRNA and mRNA Expression Changes in Glioblastoma Cells Cultivated under Conditions of Neurosphere Formation
por: Dymova, Maya A., et al.
Publicado: (2022)

Transcriptome Changes in Glioma Cells upon Infection with the Oncolytic Virus VV-GMCSF-Lact
por: Semenov, Dmitriy V., et al.
Publicado: (2023)

Complete Genome Sequence of Vaccinia Virus Strain L-IVP
por: Shvalov, Alexander N., et al.
Publicado: (2016)

The Signaling Pathways Controlling the Efficacy of Glioblastoma Therapy
por: Vasileva, N. S., et al.
Publicado: (2022)

Transcriptome Changes in Glioma Cells Cultivated under Conditions of Neurosphere Formation
por: Vasileva, Natalia S., et al.
Publicado: (2022)

Features of the Antitumor Effect of Vaccinia Virus Lister Strain
por: Zonov, Evgeniy, et al.
Publicado: (2016)

Molecular Mechanisms of Drug Resistance in Glioblastoma
por: Dymova, Maya A., et al.
Publicado: (2021)

Apoptin enhances the oncolytic properties of vaccinia virus and modifies mechanisms of tumor regression
por: Kochneva, Galina, et al.
Publicado: (2014)

Tumor-Specific Peptide, Selected from a Phage Peptide Library, Enhances Antitumor Activity of Lactaptin
por: Nemudraya, Anna A., et al.
Publicado: (2016)

Recombinant Lactaptin Induces Immunogenic Cell Death and Creates an Antitumor Vaccination Effect in Vivo with Enhancement by an IDO Inhibitor
por: Troitskaya, Olga, et al.
Publicado: (2020)

Modification of a Tumor-Targeting Bacteriophage for Potential Diagnostic Applications
por: Dymova, Maya Alexandrovna, et al.
Publicado: (2021)

Tumor-Targeting Peptides Search Strategy for the Delivery of Therapeutic and Diagnostic Molecules to Tumor Cells
por: Dmitrieva, Maria D., et al.
Publicado: (2020)

Human Blood Extracellular Vesicles Activate Transcription of NF-kB-Dependent Genes in A549 Lung Adenocarcinoma Cells
por: Savinovskaya, Yulya I., et al.
Publicado: (2022)

Lactaptin Induces p53-Independent Cell Death Associated with Features of Apoptosis and Autophagy and Delays Growth of Breast Cancer Cells in Mouse Xenografts
por: Koval, Olga A., et al.
Publicado: (2014)

Construction of Recombinant Human GM-CSF and GM-CSF-ApoA-I Fusion Protein and Evaluation of Their Biological Activity
por: Pykhtina, Mariya, et al.
Publicado: (2021)

A Human Multi-Epitope Recombinant Vaccinia Virus as a Universal T Cell Vaccine Candidate against Influenza Virus
por: Goodman, Alan G., et al.
Publicado: (2011)

Defective Regulation of Membrane TNFα Expression in Dendritic Cells of Glioblastoma Patients Leads to the Impairment of Cytotoxic Activity against Autologous Tumor Cells
por: Tyrinova, Tamara, et al.
Publicado: (2020)

Live-Cell Imaging of Vaccinia Virus Recombination
por: Paszkowski, Patrick, et al.
Publicado: (2016)

Use of a Recombinant Vaccinia Virus Expressing Interferon Gamma for Post-Exposure Protection against Vaccinia and Ectromelia Viruses
por: Holechek, Susan A., et al.
Publicado: (2013)

Characterization of primary normal and malignant breast cancer cell and their response to chemotherapy and immunostimulatory agents
por: Nushtaeva, Anna A., et al.
Publicado: (2018)

Boron neutron capture therapy: Current status and future perspectives
por: Dymova, Mayya Alexandrovna, et al.
Publicado: (2020)

Vaccinia Virus Recombinants: Expression Vectors and Potential Vaccines
por: MACKETT, M.
Publicado: (1994)

Systemically administered DNA and fowlpox recombinants expressing four vaccinia virus genes although immunogenic do not protect mice against the highly pathogenic IHD-J vaccinia strain
por: Bissa, Massimiliano, et al.
Publicado: (2013)

Nucleotide Modifications Decrease Innate Immune Response Induced by Synthetic Analogs of snRNAs and snoRNAs
por: Stepanov, Grigory, et al.
Publicado: (2018)

Interplay Between Mitophagy and Apoptosis Defines a Cell Fate Upon Co-treatment of Breast Cancer Cells With a Recombinant Fragment of Human κ-Casein and Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand
por: Wohlfromm, Fabian, et al.
Publicado: (2021)

Phase I Safety and Immunogenicity Evaluation of MVA-CMDR, a Multigenic, Recombinant Modified Vaccinia Ankara-HIV-1 Vaccine Candidate
por: Currier, Jeffrey R., et al.
Publicado: (2010)

Protection against highly pathogenic SIV by BCG-SIV recombinant priming and attenuated replicating vaccinia-SIV recombinant boosting
por: Zhang, X, et al.
Publicado: (2012)

Cytotoxic and Antitumor Activity of Lactaptin in Combination with Autophagy Inducers and Inhibitors
por: Bagamanshina, Anastasia V., et al.
Publicado: (2019)

Modified Vaccinia Virus Ankara as a Viral Vector for Vaccine Candidates against Chikungunya Virus
por: García-Arriaza, Juan, et al.
Publicado: (2021)

AIDS recombinant vaccine; recombinant HIV virus core protein cloning in vaccinia virus vector
Publicado: (1991)

Enzymatic processing of replication and recombination intermediates by the vaccinia virus DNA polymerase
por: Hamilton, Michael D., et al.
Publicado: (2005)

Successive site translocating inoculation potentiates DNA/recombinant vaccinia vaccination
por: Ren, Yanqin, et al.
Publicado: (2015)

Chapter 7 Use of Recombinant Vaccinia Virus Vectors for Cell Biology
por: Weisz, Ora A., et al.
Publicado: (1994)

Generation of recombinant vaccinia virus and analysis of virus-induced cell death
por: Liu, Zhijun, et al.
Publicado: (2021)

Antitumor activity of recombinant oncolytic vaccinia virus with human IL2
por: Liu, Liqiong, et al.
Publicado: (2022)

Oncolytic therapy with recombinant vaccinia viruses targeting the interleukin-15 pathway elicits a synergistic response
por: Shakiba, Yasmin, et al.
Publicado: (2023)

Enhancing the Immunogenicity of Vaccinia Virus
por: Shchelkunov, Sergei N., et al.
Publicado: (2022)

Aptamers Enhance Oncolytic Viruses’ Antitumor Efficacy
por: Dymova, Maya A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fdj4v9emoqvc3gmo01u2tb08c1